| Literature DB >> 19742122 |
Rico Lippmann1, Stephanie Kaspar1, Twan Rutten1, Michael Melzer1, Jochen Kumlehn1, Andrea Matros1, Hans-Peter Mock1.
Abstract
The secretome of a tobacco cell suspension culture was investigated by a combined proteomic and metabolomic approach. Protein analysis from 2-DE gels led to identification of 32 out of 60 spots from culture medium. Identified proteins were mainly involved in stress defence and cell regeneration processes. Among them three putative new isoforms, e.g. for chitinase, peroxidase and beta-1,4-xylosidase were identified, not yet present in available protein databases for the genus Nicotiana. GC-MS analysis of time course experiments revealed significant changes for metabolites involved in energy transport, signalling and cell development. Among them, the most significant increase was found for putrescine in the medium of cultures entering the exponential phase. Results showed strong abundance of stress associated proteins and metabolites in the absence of elicitors or additional stress treatments.Entities:
Keywords: apoplast; extracellular proteins; secreted putrescine; suspension culture; tobacco
Mesh:
Substances:
Year: 2009 PMID: 19742122 PMCID: PMC2738909 DOI: 10.3390/ijms10073012
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1.Growth curve and viability of S2LS3 cell culture.
A) Growth rate as packed cell volume (PCV) out of 5 mL (n=4, open circle). The viability of cell culture was counted after labelling with the vitality dye fluorescine diacetate (FDA) as percentage of living cells (black circle). Error bars represent the standard deviation of mean values. Over 500 cells were counted for calculation (n=2) B) Fluorescence images of different time points. Cell culture was stained with FDA to monitor cell viability and cells emitting green fluorescence were counted as vital. Fluorescence was visualised in a CLSM using a 488 nm laser line in combination with a 505–530 nm band pass filter. The scale bars represent 500 μm on all images.
Figure 2.Protein separation by two-dimensional gel electrophoresis (2-DE).
A) 2-DE analysis of total secreted proteins of S2LS3 cells after 7 days of cultivation. Separation was performed in 1st dimension at pH 3-10 and in 2nd dimension with 11.25 % acrylamide. After staining with CBB over 60 spots were detectable. B) Enlarged view of marked region from 2-D gel of secreted proteins from S2LS3 cells. C) Representative 2-D gel of intracellular proteins from cell culture for comparison with protein intensities of secreted proteins.
Figure 3.Comparison of spot intensities from biological replicates.
Selected low (#58 & 47), middle (#59 & 11) and high (#02 & 28) abundant proteins from four biological replicates calculated with Progenesis SameSpots software were shown. Intensities are presented as normalized spot volume and showed no significant changes between individual replicates.
Identification of secreted proteins from 2-DE analysis of culture medium. Identified proteins together with the corresponding organism, accession number, peptides, theoretical isoelectric point (pI), molecular weight (Mw), and annotation of signal peptides are listed. Molecular weight and pI were not available for identified EST-clones. When, database searches lead to the identification of the same protein for several spots data were summarized. Individual databases are indicated as a) TREMBL, b) TIGR and c) Swissprot. Annotations for signal peptide were estimated from N-terminal sequences (70 aa) with SignalP 3.0 (http://www.cbs.dtu.dk/services/SignalP) and the following settings: organism was eukaryotes and method was hidden Markov model with a positive result at a probability higher than 0.55).
| 1, 2, 3, and 4 | Xylan 1,4 beta xylosidase a | Q2MCJ5 | (K)AVSNNFATLMR(L) | 81423 | 6,0 | yes | |
| LEXYL2 protein Fragment a | Q76MS4 | (K)VTQQDLDDTFNPPFK(S) | 68868 | 7,7 | no | ||
| (K)VDMTNMNMR(A) | |||||||
| homologue to LEXYL2 protein Fragment Q76MS4 b | TC145815 | (T)AVSNNFATLMR(T) | no | ||||
| (T)VTQQDLDDTFNPPFK(C) | |||||||
| (T)AVSNNFATLMR(T) Ox (M10) | |||||||
| similar to Q76MS4 LEXYL2 protein Fragment partial 37 b | TC13056 | (A)LPMTWYPQSYADK(T) | |||||
| (A)LPMTWYPQSYADK(T) Ox (M3) | |||||||
| (G)VDMTNMNMR(G) | |||||||
| (A)GPTVFNFGDGLSYSNYK(C) | |||||||
| 12, 14, 15, 22 | Xylan 1,4 beta xylosidase a | Q2MCJ5 | (K)AVSNNFATLMR(L) | 81423 | 6,0 | Yes | |
| 18, 20, 21, | Beta xylosidase like protein a | Q9LXD6 | (R)LGFFDGDPK(S) | 83168 | 7,2 | yes | |
| 22, and 23 | LEXYL2 protein Fragment a | Q76MS4 | (K)VTQQDLDDTFNPPFK(S) | 68868 | 7,7 | no | |
| homologue to Q76MS4 LEXYL2 protein Fragment partial 88 b | TC145815 | (C)AVSNNFATLMR(G) | no | ||||
| (T)VTQQDLDDTFNPPFK(C) | |||||||
| similar to Q76MS4 LEXYL2 protein Fragment partial 37 b | TC13056 | (C)LPMTWYPQSYADK(T) | |||||
| 25 | Alpha galactosidase Fragment a | Q6UAY5 | (K)TFASWGVDYLK(Y) | 31305 | 4,7 | no | |
| 27 | LEXYL2 protein Fragment a | Q76MS4 | (K)VTQQDLDDTFNPPFK(S) | 68868 | 7,7 | no | |
| Xylan 1,4 beta xylosidase a | Q2MCJ5 | (K)AVSNNFATLMR(L) | 81423 | 6,0 | yes | ||
| homologue to Q76MS4 LEXYL2 protein Fragment partial 88 b | TC145815 | (T)VTQQDLDDTFNPPFK(C) | no | ||||
| (T)AVSNNFATLMR(T) | |||||||
| 34 | Glucan endo 1,3 beta glucosidase acidic isoform PR Q precursor c | P36401 | (R)IYDPDQPTLEALR(G) | 36971 | 5,0 | yes | |
| (R)YIAVGNEVSPLNENSK(Y) | |||||||
| (K)YVPVLLNAMR(N) | |||||||
| (R)NIQTAISGAGLGNQIK(V) | |||||||
| (K)VSTAIETGLTTDTSPPSNGR(F) | |||||||
| 35 | Alpha galactosidase a | Q5DUH7 | (K)LGIYSDAGTQTCSK(T) | 41203 | 5,5 | no | |
| 37, 38 | Xyloglucan endotransglucosylase hydrolase XTH3 a | Q6RHY0 | (R)IIFYVDGTPIR(E) | 32134 | 5,1 | yes | |
| homologue to Q6RHY0 Xyloglucan endotransglucosylase b hydrolase XTH3 partial | TC5192 | (A)IIFYVDGTPIR(T) | yes | ||||
| (C)APFSASYR(A) | |||||||
| homologue to Q6RHY0 endotransglucosylase hydrolase XTH3 b partial | TC186880 | (G)NSESIGVSYPK(T) | yes | ||||
| 41 | LEXYL2 protein Fragment a | Q76MS4 | (K)VTQQDLDDTFNPPFK(S) | 68868 | 7,7 | no | |
| homologue to Q76MS4 LEXYL2 protein Fragment partial 88 b | TC145815 | (T)VTQQDLDDTFNPPFK(C) | no | ||||
| (T)AVSNNFATLMR(T) | |||||||
| 52 | LEXYL2 protein Fragment complete b | TC170394 | (T)ISMLVNTAGSVSR(T) | no | |||
| 57 | Glucan endo 1 3 beta glucosidase acidic isoform PR Q c | P36401 | (R)IYDPDQPTLEALR(G) | 36971 | 5,0 | yes | |
| 57 | Subtilisin like protease a | A9XG40 | (R)TPSFLGLDR(S) | 81136 | 6,6 | yes | |
| (K)GYETTLGPVDVSK(E) | |||||||
| Subtilisin like protease a | A9XG41 | (R)TPSFLGLDR(S) | |||||
| (K)GYETTLGPVDVSK(E) | 81123 | 6,7 | yes | ||||
| 6 | Subtilisin like protease a | A9XG40 | (K)GYETTLGPVDVSK(E) | 81136 | 6,6 | yes | |
| (K)VSTVFSPSNSVK(V) | |||||||
| (K)VSVEPETLVFTR(A) | |||||||
| Subtilisin like protease a | A9XG41 | (K)GYETTLGPVDVSK(E) | 81123 | 6,7 | yes | ||
| (K)VSTVFSSSNSVK(V) | |||||||
| (K)VSVEPETLVFTR(V) | |||||||
| 45, 46, | CHIP TOBAC Acidic endochitinase P precursor c | P17513 | (R)GPIQLTNQNNYEK(A) | 27452 | 4,7 | yes | |
| (R)QDLVNNPDLVATDATISFK(T) | |||||||
| 47 | Chitinase a | Q207U1 | (R)SFPGFGTTGDDATR(K) | 34034 | 8,1 | yes | |
| CHIQ TOBAC Acidic endochitinase Q precursor c | P17514 | (R)WTPSAADQAANR(V) | 27615 | 4,9 | yes | ||
| CHIP TOBAC Acidic endochitinase P precursor c | P17513 | (R)GPIQLTNQNNYEK(A) | 27452 | 4,7 | yes | ||
| 11 | Peroxidase a | Q18PR1 | (R)ISPLTGTNGEIR(K) | 34257 | 8,2 | yes | |
| Peoxidase like protein a | Q0WLG9 | (K)DAAPNANSAR(G) | 38084 | 5,6 | yes | ||
| similar to Q9LEH3 Peroxidase precursor partial 91 b | TC12826 | (T)GFDVVDNIK(A) | yes | ||||
| 24 | Lignin forming anionic peroxidase c | P11965 | (K)DAPANVGAGGFDIVDDIK(T) | 34652 | 4,5 | yes | |
| (K)GPSWQVLFGR(K) | |||||||
| (K)GMDLTDLVALSGAHTFGR(A) Ox (M2) | |||||||
| (K)LGNISPLTGTNGQIR(T) | |||||||
| 36 | Biotic cell death associated protein a | Q850R9 | (K)IEDGFVTTGGIK(G) | 25141 | 8,6 | yes | |
| 49 | Biotic cell death associated protein a | Q850R9 | (K)IEDGFVTTGGIK(G) | 25141 | 8,6 | yes | |
| 55, 58 | Pathogenesis related protein 1B c | P07053 | (K)AVEMWVDEK(Q) | 18487 | 5,2 | yes | |
| (K)AVEMWVDEK(Q) Ox (M4) | |||||||
| Pathogenesis related protein 1A c | P08299 | (K)AVEMWVDEK(Q) | 18561 | 4,6 | yes | ||
| (K)AVEMWVDEK(Q) Ox (M4) | |||||||
| Pathogenesis related protein 1C c | P09042 | (K)AVEMWVNEK(Q) | 18570 | 5,2 | yes | ||
Figure 4.Alignment of amino acid sequences from chitinase isoforms.
Two isoforms of endochitinase P (P17513) and Q (P17514) from N. tabacum and one chitinase (Q207U1) from M. charantia were aligned. Identified peptides for each chitinase were marked in grey, and in black amino acids are signed which are unique for isoforms. Alignment was performed with CLUSTAL 2.0.10 multiple sequence alignment from UniProt.
Figure 5.Proteins clustered to their functional activity.
Functional activity and processes were clustered according to GO annotation (UniProt protein database) of biological process.
Figure 6.GC-MS analysis of extracellular metabolite profiles from S2LS3 cell culture medium after derivatisation. Exact mass retention time pairs (EMRT) were used for principle component analysis (PCA).
A) Representative total ion current (TIC) chromatogram at day 7. The y-axis was set to 25% of the base peak. B) Loading Plot from PCA. C) Score Plot calculated from the Loading Plot with component 1 and 2. Samples belonging to the same cultivation time (1d, 3d, 5d, and 7d, n = 6) were marked with black circles.
Putative identity of compounds detected in the medium of S2LS3 culture. Metabolites were identified by matching their spectra to NIST library and the Golm metabolomics database. Retention time (RT), retention index (RI) calculated with alkanes; the match values from Nist, and the intensities (peak area) of a compound-specific molecular fragment (specific ion, m/z) at different time points are shown. Values for peak area are given Not identified values were signed with n.i. and intensities under the detection limit signed with n.d.
| 190,99 | 6,58 | 1010 | 1051 | 883 | 884 | 492±124 | 606±218 | 726±188 | 667±66 | |
| 105,03 | 11,03 | 1244 | 1253 | 789 | 851 | n.d | 12±2 | 11±2 | 10±1 | |
| 117,07 | 22,34 | 1714 | 1721 | 723 | 744 | 7±3 | 48±11 | 124±22 | 131±14 | |
| 174,11 | 22,68 | 1729 | 1745 | 894 | 895 | 20±9 | 9±2 | 369±80 | 492±115 | |
| 217,07 | 23,31 | 1758 | n.i. | n.i. | n.i. | 246±77 | 272±73 | 191±38 | 93±10 | |
| 364,00 | 25,62 | 1870 | 1865 | 873 | 874 | 1200±175 | 1440±249 | 1306±210 | 410±84 | |
| 364,18 | 25,82 | 1880 | 1774 | 878 | 880 | 959±104 | 1142±200 | 286±30 | 360±70 | |
| 364,18 | 26,07 | 1893 | 1888 | 908 | 923 | 455±65 | 286±30 | 151±9 | 19±3 | |
| 364,18 | 26,39 | 1908 | 1910 | 828 | 918 | 11±1 | 10±2 | 2±0.5 | n.d. | |
| 205,10 | 26,57 | 1917 | n.i. | n.i. | n.i. | 137±46 | 120±33 | 41±11 | 25±3 | |
| 147,10 | 26,72 | 1924 | n.i. | n.i. | n.i. | n.d | n.d | n.d | 14±3 | |
| 317,97 | 29,69 | 2082 | 2091 | 914 | 944 | 1380±260 | 4±1 | n.d. | n.d. | |
| 361,15 | 38,66 | 2636 | 2640 | 760 | 767 | saturated | saturated | saturated | saturated |
Figure 7.Relative quantification of the secreted metabolite putrescine.
A) Relative concentration of putrescine over the cultivation time (n = 5). The area of the typical fragment mass of putrescine m/z = 174.1 were used for elucidation. B) Extracted mass of m/z =174.1 showing the different peak areas of putrescine fragment as an example from one replicate.